MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $52.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was -$190.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $242.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$115.00K, a 115.01% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$230.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was -$1.35M, a 480.06% decline from fiscal 2024.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $356.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$1.65M, a 763.05% decline from fiscal 2022.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $249.00K, a 336.84% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $52.00K 10-Q · filed 2026-08-13 | -$63.00K derived: sum of 3 quarters · filed 2026-08-13 | -$293.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $242.00K 10-Q · filed 2026-05-08 | $127.00K derived: sum of 2 quarters · filed 2026-05-08 | -$103.00K derived: sum of 3 quarters · filed 2026-05-08 | -$484.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$345.00K derived: sum of 2 quarters · filed 2026-03-31 | -$726.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.35M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$611.00K derived: sum of 2 quarters · filed 2026-08-13 | -$1.24M 10-Q · filed 2025-11-10 | -$472.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$381.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.01M 10-Q · filed 2026-08-13 | -$242.00K derived: sum of 3 quarters · filed 2026-08-13 | -$646.00K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$627.00K 10-Q · filed 2026-05-08 | $139.00K derived: sum of 2 quarters · filed 2026-05-08 | -$265.00K derived: sum of 3 quarters · filed 2026-05-08 | $339.00K derived: sum of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | $766.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $362.00K derived: sum of 2 quarters · filed 2026-03-31 | $966.00K derived: sum of 3 quarters · filed 2026-03-31 | $356.00K 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $200.00K derived: sum of 2 quarters · filed 2025-11-10 | -$410.00K 10-Q · filed 2025-11-10 | -$721.00K derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$6.00K 10-Q · filed 2025-08-14 | -$317.00K derived: sum of 3 quarters · filed 2025-08-14 | $69.00K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$610.00K 10-Q · filed 2025-05-15 | -$921.00K derived: sum of 2 quarters · filed 2025-05-15 | -$535.00K derived: sum of 3 quarters · filed 2025-05-15 | $44.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $75.00K derived: sum of 2 quarters · filed 2025-04-15 | $654.00K derived: sum of 3 quarters · filed 2025-04-15 | -$1.65M 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | $386.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $965.00K derived: sum of 2 quarters · filed 2024-11-13 | -$1.34M 10-Q · filed 2024-11-13 | -$1.94M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $579.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.73M 10-Q · filed 2024-08-14 | -$2.32M derived: sum of 3 quarters · filed 2024-08-14 | -$2.92M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$2.31M 10-Q · filed 2024-05-09 | -$2.90M derived: sum of 2 quarters · filed 2024-05-09 | -$3.50M derived: sum of 3 quarters · filed 2024-05-09 | -$1.05M derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | -$597.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$1.19M derived: sum of 2 quarters · filed 2024-03-27 | $1.26M derived: sum of 3 quarters · filed 2024-03-27 | $249.00K 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -$597.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.86M derived: sum of 2 quarters · filed 2023-11-08 | $846.00K 10-Q · filed 2023-11-08 | $846.04K 10-Q · filed 2022-11-02 | $804.43K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $2.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.44M 10-Q · filed 2023-08-09 | $1.44M 10-Q · filed 2022-08-11 | $1.40M derived: sum of 3 quarters · filed 2023-08-09 | $1.53M derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$1.01M 10-Q · filed 2023-05-10 | -$1.01M 10-Q · filed 2022-05-12 | -$1.05M derived: sum of 2 quarters · filed 2023-05-10 | -$920.41K derived: sum of 3 quarters · filed 2023-05-10 | $436.58K derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | -$41.57K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $89.59K derived: sum of 2 quarters · filed 2023-03-15 | $1.45M derived: sum of 3 quarters · filed 2023-03-15 | $57.00K 10-K · filed 2023-03-15 | $55.56K 10-K · filed 2022-03-08 | |||
| 2021-09-30 | $131.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.49M derived: sum of 2 quarters · filed 2022-11-02 | $98.57K 10-Q · filed 2022-11-02 | $813.80K derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$32.59K 10-Q · filed 2022-08-11 | $682.63K derived: sum of 3 quarters · filed 2022-08-11 | $1.26M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$1.39M 10-Q · filed 2022-05-12 | -$674.36K derived: sum of 2 quarters · filed 2022-05-12 | -$94.14K derived: sum of 3 quarters · filed 2022-05-12 | $224.67K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $715.23K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $1.30M derived: sum of 2 quarters · filed 2022-03-11 | $1.61M derived: sum of 3 quarters · filed 2022-03-11 | $855.82K 10-K/A · filed 2022-03-11 | ||||
| 2020-09-30 | $580.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $899.03K derived: sum of 2 quarters · filed 2021-11-08 | $140.59K 10-Q · filed 2021-11-08 | $607.25K derived: sum of 4 quarters · filed 2021-11-08 | ||||
| 2020-06-30 | $318.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$439.63K 10-Q · filed 2021-08-10 | $27.03K derived: sum of 3 quarters · filed 2021-08-10 | $214.84K derived: sum of 4 quarters · filed 2021-08-10 | ||||
| 2020-03-31 | -$758.44K 10-Q · filed 2021-05-10 | -$291.78K derived: sum of 2 quarters · filed 2021-05-10 | -$103.97K derived: sum of 3 quarters · filed 2021-05-10 | $160.40K derived: sum of 4 quarters · filed 2021-05-10 | ||||
| 2019-12-31 | $466.66K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $654.47K derived: sum of 2 quarters · filed 2021-03-29 | $918.84K derived: sum of 3 quarters · filed 2021-03-29 | $842.56K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $187.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $452.18K derived: sum of 2 quarters · filed 2020-11-06 | $375.90K 10-Q · filed 2020-11-06 | $704.43K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $264.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $188.09K 10-Q · filed 2020-08-10 | $516.62K derived: sum of 3 quarters · filed 2020-08-10 | $335.36K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$76.28K 10-Q · filed 2020-05-11 | $252.25K derived: sum of 2 quarters · filed 2020-05-11 | $70.99K derived: sum of 3 quarters · filed 2020-05-11 | $548.36K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $328.53K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $147.27K derived: sum of 2 quarters · filed 2020-03-09 | $624.63K derived: sum of 3 quarters · filed 2020-03-09 | $97.78K 10-K · filed 2020-03-09 | ||||
| 2018-09-30 | -$181.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $296.11K derived: sum of 2 quarters · filed 2019-11-13 | -$230.74K 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | $477.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$49.48K 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | -$526.85K 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | $159.36K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |